Williamson Stephen, Senior VP and CFO, has executed 39 insider transactions across two companies—Thermo Fisher Scientific (TMO) and Honeywell (HON)—with a clear net selling bias. SEC Form 4 filings reveal total sales of $27.8 million against purchases of $9.87 million, indicating a nearly three-to-one ratio favoring disposals. His most recent activity in February 2026 involved multiple sales of TMO shares totaling $960,711.10 across four transactions, with individual sales ranging from $128,750 to $351,605. Prior to that, in August 2025, he sold TMO shares in eight separate transactions worth between $54,462 and $116,500, collectively exceeding $800,000.
Stephen’s trading history also includes smaller transactions in HON, with two January 2026 sales at $59,999 each and two October 2025 sales at $33,750 apiece. Notably, several filings—particularly in February 2025 and February 2026—involved transactions coded as "A" (award) or "G" (gift) with zero reported value, suggesting equity grants or transfers rather than open-market trades. While his recent activity shows no new buys, the pattern reflects consistent monetization of holdings, particularly in TMO, where the bulk of his transactions have occurred. The absence of recent purchases contrasts with earlier years, reinforcing a dispositional trend rather than accumulation.
AI-assisted summary